Exciting News From the Cystic Fibrosis Drug Pipeline: Antimicrobials and CFTR Modulators

We have been beyond fortunate to see some really positive news coming from the Pipeline over the past couple of weeks and months. First, a potential breathtaking (science pun!) antimicrobial from Vast Therapeutics is looking to conquer chronic infection in cystic fibrosis. Vast Therapeutics is “a preclinical stage pharmaceutical company focused on delivering the power...
Continue reading...

We Are a Community of Individuals

A discussion in the comments on one of my Facebook posts from the other day highlighted an interesting (and often overlooked) part of the cystic fibrosis world – people have very different individual needs. Here are some of the comments: Ultimately the topic here is the ACA – Affordable Care Act (Obamacare). We’ll touch on...
Continue reading...